| http://www.w3.org/ns/prov#value | - After 20 years, one method estimates the cumulative benefits at $13,130 million and the second method estimates the cumulative benefits at $26,757 million. (ii) Agency actions relevant to the Regulatory Flexibility Act, 5 U.S.C. Secs. 603-605, 607, and 609 The FDA performed a Final Regulatory Flexibility Analysis of the final rule, which contains the information required by the Act including the n
|
